Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Progress in the study of stem Leydig cells].

Si-Xiao Zhang1, Qiang Dong

  • 1Department of Urology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.

Zhonghua Nan Ke Xue = National Journal of Andrology
|December 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary Brainstem Hemorrhage: A Review of Prognostic Factors and Surgical Management.

Frontiers in neurology·2021
Same author

Assessing the Relative Value of CT Perfusion Compared to Non-contrast CT and CT Angiography in Prognosticating Reperfusion-Eligible Acute Ischemic Stroke Patients.

Frontiers in neurology·2021
Same author

Herpesvirus infections and Alzheimer's disease: a Mendelian randomization study.

Alzheimer's research & therapy·2021
Same author

Identification of embolic stroke in patients with large vessel occlusion: The Chinese embolic stroke score, CHESS.

CNS neuroscience & therapeutics·2021
Same author

Staging tau pathology with tau PET in Alzheimer's disease: a longitudinal study.

Translational psychiatry·2021
Same author

Genetically determined low income modifies Alzheimer's disease risk.

Annals of translational medicine·2021

Stem Leydig cells (SLCs) offer therapeutic potential for treating testosterone deficiency. These cells can be harvested, expanded, differentiated in vitro, and reimplanted to restore androgen levels in males.

Area of Science:

  • Endocrinology
  • Stem Cell Biology
  • Reproductive Medicine

Context:

  • Leydig cells are the principal producers of testosterone in the testes.
  • Testosterone deficiency (androgen deficiency) affects numerous males and can result from various underlying causes.
  • Stem Leydig cells (SLCs) represent an undifferentiated progenitor population crucial for Leydig cell development.

Purpose:

  • To explore the therapeutic potential of stem Leydig cells (SLCs) for treating male androgen deficiency.
  • To outline a potential cell therapy paradigm involving SLCs for restoring testosterone levels.

Summary:

  • Leydig cells, the primary source of testosterone, originate from stem Leydig cells (SLCs).
  • SLCs possess significant therapeutic potential for addressing androgen deficiency.

Related Experiment Videos

  • A proposed cell therapy involves harvesting, in vitro expansion and differentiation, and subsequent reimplantation of SLCs.

    • Impact:

    • This approach could provide a novel therapeutic strategy for males with hypogonadism.
    • Successful implementation may restore physiological testosterone levels and improve quality of life.
    • Further research into SLC biology and therapeutic applications is warranted.